ARCHIVES

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

NCI May Rent Chimps to Test AIDS Vaccines

November 29, 1985

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010

Trial Combines Drugs Against Blood Vessel Formation

October 26, 2007

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

October 14, 1977

ACS To Offer 10 Nurse Scholarships

July 18, 1980